Cited by 36Cerebrospinal fluid and hydrocephalusBarrier Structure and Function StudiesIntravenous Infusion Technology and Safety

Large-Volume Intrathecal Administrations: Impact on CSF Pressure and Safety Implications

Open access
Belov, Vasily, Appleton, Janine, Levin, Stepan, Giffenig, Pilar, Durcanova, Beata, Papisov, Mikhail·2021·Frontiers in Neuroscience

Abstract

The increasing number of studies demonstrates the high potency of the intrathecal (IT) route for the delivery of biopharmaceuticals to the central nervous system (CNS). Our earlier data exhibited that both the infused volume and the infusion rate can regulate the initial disposition of the administered solute within the cerebrospinal fluid (CSF). This disposition is one of key factors in defining the subsequent transport of the solute to its intended target. On the other hand, fast additions of large volumes of liquid to the CSF inevitably raise the CSF pressure [a.k.a. intracranial pressure (ICP)], which may in turn lead to adverse reactions if the physiologically delimited threshold is exceeded. While long-term biological effects of elevated ICP (hydrocephalus) are known, the safety thresholds pertaining to short-term ICP elevations caused by IT administrations have not yet been characterized. This study aimed to investigate the dynamics of ICP in rats and non-human primates (NHPs) with respect to IT infusion rates and volumes. The safety regimes were estimated and analyzed across species to facilitate the development of translational large-volume IT therapies. The data revealed that the addition of a liquid to the CSF raised the ICP in a rate and volume-dependent manner. At low infusion rates (<0.12 ml/min in rats and <2 ml/min in NHPs), NHPs and rats displayed similar tolerance patterns. Specifically, safe accommodations of such added volumes were mainly facilitated by the accelerated pressure-dependent CSF drainage into the blood, with I stabilizing at different levels below the safety threshold of 28 ± 4 mm Hg in rats and 50 ± 5 mm Hg in NHPs. These ICPs were safely tolerated for extended durations (of at least 2–25 min). High infusion rates (including boluses) caused uncompensated exponential ICP elevations rapidly exceeding the safety thresholds. Their tolerance was species-dependent and was facilitated by the compensatory role of the varied components of craniospinal compliance while not excluding the possibility of other contributing factors. In conclusion, large volumes of liquids can safely be delivered via IT routes provided that ICP is monitored as a safety factor and cross-species physiological differences are accounted for.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2021.604197

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intrathecal injection is less invasive, commonly used in clinical and preclinical settings, and allows repeated dosing with minimal systemic exposure and off-target effects.

    “Moreover, IT injection is less invasive, commonly used in both clinical and preclinical settings, and allows for repeated dosing with minimal systemic exposure and off-target effects.[23]”

    From Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection (2025) · cites this paper as [23]

    The Introduction (page unavailable) describes intrathecal lumbar delivery as less invasive than intracerebroventricular delivery, usable for chronic or repeated dosing, and relevant to both clinical and preclinical use. It does not establish minimal systemic exposure or off-target effects; it notes clearance of injected compounds into the blood. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Belova E. Vallance L. Belov V. Gagne M. Gillooly C. Papisov M. I. (2012). “ PET-based approaches to studying the size-dependence of leptomeningeal drug clearance,” in Proceedings of the Abstracts of 39th Annual Meeting of the Controlled Release Society, Quebec, Canada (Mount Laurel, NJ: CRS).
  2. Farris E. J. Griffith J. Q. (1949). The Rat in Laboratory Investigation. Philadelphia, PA: Lippincott Company.

Cited by

Sorted by citations

Authors
Belov, V., Appleton, J., Levin, S., Giffenig, P., Durcanova, B., & Papisov, M.
Affiliations
  • Harvard University (US)
  • Massachusetts General Hospital (US)
Corresponding author
Belov, Vasily
Venue
Frontiers in Neuroscience
Published
2021-04-14
Volume
15
Pages
604197-604197
ISSN
1662-453X (ISSN-L)
OpenAlex
W3034445344
Cited by
36
References
63
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 8 · 2022: 4
FWCI
2.54
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • arXiv (Cornell University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • arXiv (Cornell University)
Funders
National Institutes of Health (R01NS092838, R21NS090049)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
Keywords
intrathecal drug delivery, intracranial pressure, cerebrospinal fluid pressure, infusion rate, infusion volume, cerebrospinal fluid drainage, craniospinal compliance, safety thresholds, species differences, non-human primates, rats, brain drug delivery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review